Densitas Announces Presentations at RSNA, Research Validates intelliMammo(TM) for Mammography Quality Improvement

09-11-2022 14:01 | 3 maanden geleden Economie

Dit is een origineel bericht van
PR Newswire

HALIFAX, NS, Nov. 9, 2022 /PRNewswire/ -- Densitas® Inc., a global provider of A.I. solutions for digital mammography and breast screening, announced that three quality improvement studies will be presented at the Radiological Society of North America (RSNA) 2022 Annual Scientific Meeting in Chicago.

In breast cancer screening, diagnostic confidence and breast cancer detection are predicated on having high quality images. Prior audits have shown that as many as 50% of mammograms do not meet image quality standards, 80% of which are due to poor positioning.

The three Quality Improvement Report presentations evaluate the densitas® intelliMammo(TM) A.I. tool for mammography quality improvement.

Information on the abstracts is as follows:

Can A.I. Support Mammography Image Quality Improvement? Primary Author: Georgia Spear, MD Date/Time: Tuesday, November 29, 2022/ 9:00am - 9:30am (Central) Location: Learning Center - QI DPS

Evidence-based assessment of quality improvement in positioning requires benchmarking of population-level error rates against which quality improvement initiatives can be evaluated. Non-subjective and standardized quality assessment is foundational to benchmarking. As a first step towards establishing population-based benchmarks of mammography positioning error rates at NorthShore University HealthSystem, this study seeks to validate the ability of an A.I. tool that generates standardized positioning quality assessments to capture the expected associations between positioning errors and varying patient and acquisition parameters. The results of the study show that breast density, breast volume, breast area, breast thickness, and compression pressure were associated with numerous positioning errors.

Investigating the Feasibility of Using A.I. For Population-Level Mammography Image Quality Improvement Initiatives at Leeds Teaching Hospitals NHS Trust Primary Author: Nisha Sharma, MBChD, FRCR Date/Time: Wednesday, November 30, 2022/ 12:45pm - 1:15pm (Central) Location: Learning Center - QI DPS

The study investigates the current state of mammography image quality in breast imaging services at Leeds Teaching Hospitals NHS Trust and presents results on the reliability and reproducibility of A.I.-generated, population-based error rates and agreement between radiographers and the A.I. tool. The results of the study show that agreement between radiographers and the A.I. tool was excellent to nearly perfect, and A.I.-generated positioning error rates were consistent with reported error rates in the literature.

Driving mammography Image Quality Improvement Using A.I. in Guyana During the COVID-19 Pandemic Primary Author: Mohamed Abdolell, MSc Date/Time: Sunday, November 27, 2022/ 12:15 pm - 12:45 pm (Central) Location: Learning Center - QI DPS

This study evaluates the impact of the adoption of an A.I. tool on mammography image quality in Georgetown General Hospital, Guyana, a radiologically underserved low- and middle-income country. The results of the study show that after adoption of the A.I. tool, positioning error rates decreased substantially and MIT-radiologist communications improved to guide effective remote mammography positioning training.

Densitas® will demonstrate intelliMammo(TM) at the upcoming Radiological Society of North America (RSNA) annual meeting, November 27-30, 2022 (Booth #2605, South Hall Level 3).

Densitas® is a global leader in artificial intelligence solutions for breast cancer screening, focused on quality, safety, efficiency, and precision breast health. Densitas® designs intuitive solutions that boost the ability of hospitals and imaging centers that perform mammography to improve efficiencies, meet FDA/ACR compliance requirements, and support early breast cancer detection and treatment. For more information, visit www.densitashealth.com.

Media Contact: Densitas®, Jessie Allen, jessie.allen@densitashealth.com, 902-292-7159

View original content:https://www.prnewswire.co.uk/news-releases/densitas-announces-presentations-at-rsna-research-validates-intellimammo-for-mammography-quality-improvement-301672960.html

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Andere persberichten van deze organisatie

Cybertrust Japan Integrates Quantum-Computing-Hardened Private Keys from Quantinuum into New IoT Authentication Platform

Japan's first commercial certificate authority incorporating Quantinuum's Quantum Origin solution to strengthen security protections for IoT devices against current and future threats CAMBRIDGE, England and BROOMFIELD, Colo., Jan. 31, 2023 /PRNewswire/ -- Quantinuum, the world's leading integrated quantum computing company, today announced that Cybertrust Japan Co., Ltd., Japan's leading certificate authority, has integrated its Quantum Origin qu
10 minuten geleden

Carbon footprint reporting and reduction made easy with Plan Be Eco

WARSAW, Jan. 31, 2023 /PRNewswire/ -- While C-level executives discuss taking climate action to improve the company's reputation and save money, small business owners worry they don't have the right resources to meet carbon footprint reporting regulations. Entrepreneurs need rights tools. According to UN baked SME Climate Hub, 68% of small business owners worry they don't have the right resources to take climate action. Lack of knowledge, money,
48 minuten geleden

Firmenich recognized as one of the world's most dynamic innovators by LexisNexis

Second consecutive year for Firmenich to feature as the only fragrance & taste company in the LexisNexis(®) 'Innovation Momentum 2023: Global Top 100 report' GENEVA, Jan. 31, 2023 /PRNewswire/ -- Firmenich, the world's largest privately-owned fragrance and taste company, is proud to announce its inclusion in the 'Innovation Momentum 2023: Global Top 100 report' by LexisNexis(®). The report lists the top 100 leading companies advancing innovative
1 uur geleden

Plusgrade Acquires UpStay to Expand its Portfolio of Upgrade and Ancillary Revenue Solutions for the Hospitality Industry

-- Plusgrade takes another step forward in becoming the global ancillary revenue powerhouse, by expanding its portfolio further in the thriving hospitality industry -- Acquisition strengthens Plusgrade's unmatched scale across five verticals of the global travel industry -- Plusgrade now expects to generate over US$5 billion in new revenue opportunities for its partners through 2023 MONTREAL, Jan. 31, 2023 /PRNewswire/ -- Plusgrade, the leading p
1 uur geleden

Postcards From The Edge

Children worldwide call on leaders to make good on promises of universal education in ground-breaking campaign from Education Cannot Wait. NEW YORK, Jan. 31, 2023 /PRNewswire/ -- Through an innovative campaign delivered by the UN's global fund for education in emergencies, Education Cannot Wait (ECW), girls and boys worldwide are sharing "Postcards from the Edge [https://c212.net/c/link/?t=0&l=en&o=3769932-1&h=3276400041&u=https%3A%2F%2Fwww.educa
2 uur geleden

Nobu Hospitality Announces Nobu Hotel, Restaurant, and Residences Al Marjan Island Underscoring Its Regional Presence

NEW YORK, Jan. 31, 2023 /PRNewswire/ -- Nobu Hospitality, the luxury lifestyle brand founded by Nobu Matsuhisa, Robert De Niro and Meir Teper, has signed a management agreement with Enevoria Development FZ-LLC, to develop the Nobu Hotel, Restaurant, and Residences on Al Marjan Island in Ras Al Khaimah. This is the brand's second hotel and residence development in the UAE following the announcement of Abu Dhabi in late 2022. The Nobu Hotel, Restau
2 uur geleden